RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF FRAGMENTS/PARTIAL PEPTIDES OF PROVASOPRESSIN, ESPECIALLY COPEPTIN OR NEUROPHYSIN II

摘要

The invention relates to a method for risk stratification for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) and angina pectoris (AP), where provasopressin (proAVP) or fragments and partial peptides thereof, especially copeptin or neurophysin II, is determined by means of an in vitro diagnosis.